University of Kentucky will lead a consortium of academic institutions participating in a US government-funded commercialisation hub intended to accelerate biomedical research.

University of Notre Dame and Indiana University have both backed a $9m seed fund aimed at supporting local businesses in life sciences, health IT and agricultural biosciences.

Apollo Hospitals is among the contributors to the fund, which will back innovative health technology developers in South and Southeast Asia.

Rutgers University was among a string of limited partners for the growth equity firm's ninth fund, which was oversubscribed from its $300m target.

University of Maryland-founded artificial lung developer Breethe is targeting $5m for its latest round after previously raising approximately $7.8m.

The George Washington spinout had previously raised $4.1m in equity for its low-voltage implantable cardiac defibrillator.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

The Pfizer and Gilead-backed immuno-oncology therapy developer, which had raised $300m in an April series A round, floated at the top of its range.

American Family Insurance was among a string of limited partners for the growth equity firm's ninth fund, which was oversubscribed from its $300m target.

Proteus Digital Health has received $88m in equity funding and upfront payments as it extended its collaboration partnership with Otsuka Pharmaceutical.